| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.dipnapharmachem.com | |
| Market Cap | 22.92 Cr. | |
| Enterprise Value(EV) | 40.74 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.38 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 25.13 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 65.04 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 15.15 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 0.63 | Calculated using Price: 9.53 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 2.40 Cr. | 24,045,250 Shares |
| FaceValue | 10 | |
| About Dipna Pharmachem Ltd. | ||
| Dipna Pharmachem is a trader, importer, and exporter in industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation since 2011. The company’s huge portfolio includes expertise for marketing and sourcing of industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation and intermediates, assistance in setting up contract manufacturing compliance for regulated, semi-regulated pharmaceutical companies with all the global benchmark parameters of leading certificates like WHO-GMP. | ||
| 1 Day |
|
-2.07% |
| 1 Week |
|
+16.18% |
| 1 Month |
|
-11.40% |
| 3 Month |
|
-5.67% |
| 6 Month |
|
-27.91% |
| 1 Year |
|
-33.52% |
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 13.24 | 6.78 | 11.39 | 4.32 | 101.02 | 6.99 | |
| Return on Capital Employed (%) | 7.16 | 7.98 | 5.42 | 3.54 | 18.16 | 9.58 | |
| Return on Assets (%) | 0.55 | 0.25 | 0.36 | 0.11 | 3.82 | 1.6 |
| Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 0 | 0 | 1 | 1 | 2 | 24 | 25 | |
| Non Curr. Liab. | 3 | 4 | 6 | 14 | 16 | |||
| Curr. Liab. | 11 | 14 | 15 | 21 | 29 | 39 | 64 | |
| Minority Int. | ||||||||
| Equity & Liab. | 11 | 14 | 18 | 25 | 36 | 78 | 104 | |
| Non Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Curr. Assets | 11 | 14 | 18 | 25 | 36 | 78 | 104 | |
| Misc. Exp. not W/O | ||||||||
| Total Assets | 11 | 14 | 18 | 25 | 36 | 78 | 104 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 17 | 20 | 31 | 31 | 73 | 100 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 17 | 20 | 31 | 31 | 73 | 100 | |
| Total Expenditure | -16 | -20 | -30 | -31 | -71 | -97 | |
| PBIDT | 0 | 0 | 0 | 0 | 2 | 3 | |
| Interest | 0 | 0 | 0 | 0 | -1 | -1 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | ||
| Taxation | 0 | 0 | 0 | 0 | 0 | ||
| Exceptional Items | |||||||
| PAT | 0 | 0 | 0 | 0 | 1 | 1 | |
| Adjusted EPS | 3 | 2 | 3 | 1 | 57 | 1 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -3 | -2 | 3 | -21 | |||
| Cash Fr. Inv. | 0 | 0 | 0 | ||||
| Cash Fr. Finan. | 3 | 3 | -3 | 26 | |||
| Net Change | 0 | 0 | 0 | 5 | |||
| Cash & Cash Eqvt | 0 | 0 | 0 | 6 |
|
Fri, 26 Apr 2024
Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31St March 2024 Submission of Certificate under Regulation 40(9) read with Regulation 40(10) of SEBI (LODR) Regulations 2015 for the financial year ended on 31st March 2024. |
|
Thu, 25 Apr 2024
Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 26Th April 2024 To 2Nd May 2024 Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company which was supposed to be held on Friday 26th April 2024 at 2:00 P.M. is now rescheduled to Thursday 2nd May 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 to discuss and consider inter-alia:1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company.2. The proposal of sub-division of equity shares of the Company.3. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. |
|
Mon, 22 Apr 2024
Update on board meeting Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that in continuation to the intimation submitted on 8th April 2023 vide Acknowledgement No.: 7079374 to the Exchange in the meeting of the Board of Directors of the Company which will be held on Friday 26th April 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211 Siddhi Vinayak Complex Near D.A.V. School Makarba Ahmedabad Gujarat India 380055 the agenda of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis shall also be placed for discussion and consideration.Further this intimation is submitted to the reference of Board meeting held will be held on 26th April 2024 and the link of the earlier announcement is https://www.bseindia.com/xmldata/ corpfiling/AttachHis/f00282ab-9375-4f0b-bd73 2463d3c5554b.pdf |
| Fri, 26 Apr 2024 |
High Delivery Percentage
|
Making Higher Highs for 2 Days
|
High Decrease in 1 Month
|
High Decrease in 6 Months
|
High Decrease in 1 Year
|
